The discovery of a new antibody "will help us better protect the population against current and future COVID variants."

A study offers new information about late-onset treatment introduced 14 days after infection with SARS-CoV-2, the virus that causes COVID-19.

New findings about how COVID enters our cells could inform the development of more effective vaccines as additional variants emerge.

Researchers have discovered that the COVID vaccine could treat a lingering health challenge faced by some with long COVID: high blood sugar.

Placebos given with people fully knowing they are placebos, effectively manage stress—even when the they are administered remotely.

A new review highlights the global scale and impact of long COVID and explains biological mechanisms behind the condition.

A new study in hamsters indicates vaccines targeting the nose and mouth may be key to controlling spread of respiratory infections like COVID.

"This study highlights the potentially large host range SARS-CoV-2 can have in nature and really how widespread it might be."

"We believe this is a big step forward in trying to understand and provide treatment to patients with this subset of Long COVID."

"The research on declining rates of long COVID marks the rare occasion when I have good news to report regarding this virus."